ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Imagion Biosystems
0.024
+0.001
4.35%
成交量:
74.46萬
成交額:
1.79萬
市值:
1,177.42萬
市盈率:
-1.40
高:
0.024
開:
0.023
低:
0.023
收:
0.023
52周最高:
0.055
52周最低:
0.011
股本:
4.91億
流通股本:
1.72億
量比:
0.26
換手率:
0.43%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.017
每股收益(LYR):
-0.046
淨資產收益率:
-2804.87%
總資產收益率:
-83.89%
市淨率:
-3.05
市盈率(LYR):
-0.52
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
醫學影像公司Imagion Biosystems向FDA提交Magsense® Her2靶向顯影劑二期試驗新藥臨牀試驗申請
美股速递
·
02/04
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IBX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.024,"timestamp":1770613920000,"preClose":0.023,"halted":0,"volume":744626,"delay":0,"changeRate":0.04347826086956526,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":490590239,"eps":-0.017095,"marketStatus":"未開盤","change":0.001,"latestTime":"02-09 16:12:00 AEDT","open":0.023,"high":0.024,"low":0.023,"amount":17870,"amplitude":0.043478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.017095,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.023,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":0.262402767064958,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-83.89%","roe":"-2804.87%","lyrEps":-0.045985,"volumeRatio":0.262402767064958,"shares":490590239,"dividePrice":0,"high":0.024,"amplitude":0.043478,"preClose":0.023,"low":0.023,"week52Low":0.011,"pbRate":"-3.05","psRate":"11.15","week52High":0.055,"institutionHeld":0,"latestPrice":0.024,"eps":-0.017095,"divideRate":0,"volume":744626,"delay":0,"ttmEps":-0.017095,"open":0.023,"prevYearClose":0.025,"prevWeekClose":0.023,"prevMonthClose":0.024,"prevQuarterClose":0.025,"fiveDayClose":0.025,"twentyDayClose":0.029,"sixtyDayClose":0.023,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161971983","title":"醫學影像公司Imagion Biosystems向FDA提交Magsense® Her2靶向顯影劑二期試驗新藥臨牀試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1161971983","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161971983?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136219,"startTime":"0","endTime":"0","summary":"医学影像技术企业Imagion Biosystems(ASX: IBX)已正式向美国食品药品监督管理局(FDA)提交新药临床试验申请(IND),计划开展其旗舰产品Magsense® Her2靶向显影剂的二期临床试验。该显影剂采用创新纳米技术,旨在通过高精度磁共振成像实现对HER2阳性肿瘤的早期识别与定位,为乳腺癌等癌症的精准诊疗提供新方案。此次IND获批后将启动多中心临床研究,进一步验证该显影剂的安全性与成像效能,有望填补现有HER2检测技术的可视化诊断空白。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}